Table 1 Demographic characteristics of enrolled participants for flow cytometry analysis
From: TLR4+group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases
IL-5⁻NP | IL-5+NP | P value | |
---|---|---|---|
Participant number | 9 | 29 | – |
Sex (male/female) | 9/0 | 23/6 | 0.3031 |
Age (years), median (IQR) | 45 (27-68) | 51 (29-66) | 0.4514 |
Asthma (%) | 0 (0%) | 15 (51.72%) | 0.0060 |
Revision surgery (%) | 2 (22.22%) | 13 (44.83%) | 0.2733 |
Tissue biomarker | |||
IL-13 (pg/mL), median (IQR) | 80.48 (67.37-100.42) | 196.52 (135.77-223.89) | 0.0079 |
IL-5 (pg/mL), median (IQR) | 4.39 (3.245-5.83) | 201.6 (60.5–330.99) | 2.0 × 10-6 |
IFN-γ (pg/mL), median (IQR) | 27.83 (9.13-38.61) | 19.58 (9.295–37.29) | 0.9124 |
IL-17 (pg/mL), median (IQR) | 19.03 (6.545-99.55) | 6.545(6.325–6.545) | 0.0140 |
ECP (ng/mL), median (IQR) | 524.6 (230.9-1171) | 5364 (3323–8467) | 8.4 × 10-5 |
eosinophils (%), median (IQR) | 4.55 (1.88-12.03) | 42.80 (26.81–65.55) | 0.0001 |